28544-93-6

Basic information

• Product Name: 1,4-dioxepan-6-one
• Synonyms: 1,4-dioxepan-6-one
• CAS NO: 28544-93-6
• Molecular Formula: C₅H₈O₃
• Molecular Weight: 116.11522
• Product Categories: Heterocycle-other series
• Mol File: 28544-93-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 218.962°C at 760 mmHg
• Flash Point: 76.513°C
• Appearance: /
• Density: 1.13g/cm³
• Vapor Pressure: 0.122mmHg at 25°C
• Refractive Index: 1.427
• CAS DataBase Reference: 1,4-dioxepan-6-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4-dioxepan-6-one(28544-93-6)
• EPA Substance Registry System: 1,4-dioxepan-6-one(28544-93-6)

Safety Data

• Hazardous Substances Data: 28544-93-6(Hazardous Substances Data)

Usage

Description

1,4-dioxepan-6-one is an organic compound that serves as an essential intermediate in the synthesis of various chemical products. It is characterized by its unique structure, which includes a dioxepan ring and a ketone group, making it a versatile building block in organic chemistry.

Uses

Used in Chemical Synthesis:
1,4-dioxepan-6-one is used as a reactant for the synthesis of spiro ether herbicides, which are a class of compounds that exhibit herbicidal properties. These herbicides are employed in agriculture to control the growth of unwanted plants, thereby increasing crop yield and quality.
1,4-dioxepan-6-one is also used as a reactant for the synthesis of spiroheterocycl-dihydropteridinones, which are complex organic molecules with potential applications in various fields, including pharmaceuticals and materials science. The unique structure of these compounds allows for the exploration of their potential uses in drug development and other advanced applications.

InChI:InChI=1/C5H8O3/c6-5-3-7-1-2-8-4-5/h1-4H2

Upstream product

• 88664-38-4 ethyl 6-oxo-1,4-dioxepane-5-carboxylate 
• 65652-63-3 diethyl 2,2'-(ethane-1,2-diylbis(oxy))diacetate 

Downstream Products

• 798533-38-7 6-(4-methoxyphenyl)-[1,4]-dioxepan-6-ol 
• 1257388-05-8 3-(3-methoxyphenyl-1)-8,11-dioxa-1,4-diazaspiro[5.6]dodecan-5-one 
• 1257388-07-0 tert-butyl 3-(3-methoxyphenyl)-5-oxo-8,11-dioxa-1,4-diazaspiro[5.6]dodecane-1-carboxylate 
• 1257388-26-3 (R)-2-(1-(tert-butoxycarbonyl)-5-oxo-3-phenyl-8,11-dioxa-1,4-diazaspiro[5.6]dodecan-4-yl)ethanoic acid 
• 1257388-30-9 tert-butyl-3-(4-fluorophenyl)-5-oxo-8,11-dioxa-1,4-diazaspiro[5.6]dodecane-1-carboxylate 
• 1257388-32-1 tert-butyl-3-(4-fluorophenyl)-4-(2-methoxy-2-oxoethyl)-5-oxo-8,11-dioxa-1,4-diazaspiro[5.6]dodecane-1-carboxylate 
• 1257388-34-3 2-(1-(tert-butoxycarbonyl)-3-(4-fluorophenyl)-5-oxo-8,11-dioxa-1,4-diazaspiro[5.6]dodecan-4-yl)ethanoic acid 
• 1257388-38-7 2-(3-(4-fluorophenyl)-5-oxo-8,11-dioxa-1,4-diazaspiro[5.6]dodecan-4-yl)-N-((R)-2'-oxo-1,1',2',3-tetrahydrospiro[inden-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide 
• 1257388-42-3 tert-butyl 3-(3-fluorophenyl)-5-oxo-8,11-dioxa-1,4-diazaspiro[5.6]dodecane-1-carboxylate 
• 1257388-44-5 tert-butyl 3-(3-fluorophenyl)-4-(2-methoxy-2-oxoethyl)-5-oxo-8,11-dioxa-1,4-diazaspiro[5.6]dodecane-1-carboxylate 
• 1257388-46-7 2-(1-(tert-butoxycarbonyl)-3-(3-fluorophenyl)-5-oxo-8,11-dioxa-1,4-diazaspiro[5.6]dodecan-4-yl)ethanoic acid 
• 1257388-28-5 3-(4-fluorophenyl)-8,11-dioxa-1,4-diazaspiro[5.6]dodecan-5-one 
• 1257388-40-1 3-(3-fluorophenyl)-8,11-dioxa-1,4-diazaspiro[5.6]dodecan-5-one 
• 1257387-81-7 (R)-3-(3,5-difluoro-phenyl)-8,11-dioxa-1,4-diaza-spiro[5.6]dodecan-5-one 

Relevant articles and documents

TRI-CYCLE COMPOUND AND APPLICATIONS THEREOF

Disclosed in the present invention are a compound represented by formula (I), a tautomer thereof or a pharmaceutically acceptable salt, and applications thereof in the preparation of drugs for treating HBV-related diseases.

NEW 5-ALKYNYL-PYRIDINES

The present invention relates to new CGRP-antagonists of general formula I wherein R1, R2, R3, Ra, Rb, Rc, X, Y and Z are defined as mentioned hereinafter, the individual diastereomers, the individual enantiomers and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, medicaments containing these compounds, the use thereof and processes for the preparation thereof.